Accelovance vies for final nominations for the 2016 Vaccine Industry Excellence (ViE) Awards!

Thanks to your input, Accelovance has been selected as a preliminary nominee for Best CRO for the 2016 World Vaccine Congress Vaccine Industry Excellence (ViE) Awards. This award celebrates the CRO who has demonstrated significant contributions in study execution, excellence, and advocacy over the last 12 months. We believe Accelovance is deserving of this award based on our work in the US and in Africa on Ebola vaccine programs, supporting novel approaches to Typhoid vaccinations, and our industry leading and continued research associated with Influenza vaccine programs.

As part of the final nomination process, we would like to ask for your final vote for Accelovance as Best Vaccine CRO given our leadership outlined above. There are three easy steps to nominate us:

Click HERE to go to the VIE website and scroll down to the voting area Fill in your address information in Section #1 In Section #3, Best Contract Research Organization Award, Type: Accelovance, Inc. and indicate why you have nominated us! At the bottom of the page, click the SUBMIT NOMINATIONS button, and you are done!
  Please vote by March 1, 2016

Oncology Protocol Challenge

Are you working on an Early Phase Oncology protocol or study concept? Participate in the Accelovance Oncology Protocol Challenge!

What is the Accelovance Protocol Challenge?

Accelovance's Protocol Challenge is an opportunity for a confidential review and discussion of your protocol or concept document. Our experts will review your information and provide a summary of operational, therapeutic, and strategic considerations tailored to your protocol/study concept. This assessment is free of charge, with no obligation of future work. To learn more, click on the link to download an overview of Accelovance's Protocol Challenge as well as information on how to participate.


Accelovance Prepared to Meet Emerging Needs for Zika Virus Research

Accelovance, Inc. Continues Geographic and Service Expansion with Acquisition of Clinquest, Inc. & BV

Accelovance, Inc. and FHI 360 Enhance Service Offering Through International Strategic Alliance

Accelovance and ERT Partner to Implement Cloud Based Data and Analytic Solution for Clinical Trial Clients

Accelovance Continues Oncology Leadership Growth with Addition of Former Global VP, Oncology from Wyeth/Pfizer and Bayer


DPharm Europe
February 9-10, 2016 – London, UK

Outsourcing in Clinical Trials West
February 10-11, 2016 – San Mateo, CA
Booth #53

SCOPE Summit for Clinical Operations Executives
February 23-25, 2016 – Miami, FL